N-acetyl-1,6-diaminohexane

Known as: N-acetyl-1,6-hexanediamine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2006
01219862006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Hexamethylene bisacetamide (HMBA) stimulates Ca(2+) signals in murine erythroleukemia (MEL) cells serving as an important… (More)
Is this relevant?
1991
1991
A Phase I clinical trial and pharmacological study of nasogastrically administered hexamethylene bisacetamide, a polar-planar… (More)
Is this relevant?
1991
1991
The acute toxicities of the cellular differentiating agent hexamethylene bisacetamide (HMBA) in humans and animals include CNS… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
1990
1990
Hexamethylene bisacetamide (HMBA) is converted by successive deacetylation and oxidation reactions to four major metabolites; in… (More)
Is this relevant?
1989
1989
The levels at which the ornithine decarboxylase gene is regulated in murine erythroleukemic cells treated with N,N'-hexamethylene… (More)
Is this relevant?
1989
1989
6-Acetamidohexanal has been identified in human plasma and urine as a metabolite of the cell-differentiating agent, hexamethylene… (More)
Is this relevant?
1988
1988
We investigated whether leukemic cell lines could convert hexamethylene bisacetamide (HMBA) to any of the metabolites previously… (More)
  • figure 1
  • table 2
  • table 3
Is this relevant?
1987
1987
In order to further understand the clinical toxicities of hexamethylene bisacetamide (HMBA) and to allow appropriate in vitro… (More)
Is this relevant?
1986
1986
Hexamethylene bisacetamide, a compound which in vitro induces differentiation in a wide variety of human and animal cancer cell… (More)
  • table 3
  • figure 2
Is this relevant?
1986
1986
N-Acetyl-1,6-diaminohexane and 1,6-diaminohexane, formed by deacetylation of the inducer hexamethylenebisacetamide (HMBA), are… (More)
Is this relevant?